Rafet
@rftbsr9
Followers
268
Following
4K
Media
6
Statuses
355
Medical Doctor#Istanbul Faculty of Medicine#Working MD Anderson Cancer Center(Stem Cell Transplantation) In Houston#GalatasarayFan
Houston Tx
Joined September 2013
RT @MolTherapy: Harnessing engineered NK cells for refractory CD30+ lymphoma #genetherapy #celltherapy.
0
6
0
RT @lab_rezvani: Congrats to @Dr_Nick_Bikes and team on their Cancer Cell paper! CRISPR screens identify UBE2F and ARIH2 as key brakes on I….
0
4
0
RT @Dr_Nick_Bikes: Excited to share our Cancer Cell @CellPressNews article on the discovery of the IL-15 Receptor "Regulome". A technical t….
0
16
0
RT @MDAndersonNews: At #ASCO25, Dr. Katy Rezvani reviewed recent natural killer (NK) cell trials showing these cells can still be detected….
0
6
0
RT @ppisters: Headed back to HTX from Chicago and this is what I saw at @fly2ohare. The most powerful brand in cancer care - the global l….
0
13
0
RT @lab_rezvani: Congratulations to @ABiederstadt_MD on an outstanding presentation #AACR25, showcasing a novel platform for genome-wide CR….
0
10
0
RT @MDAndersonNews: This morning at #AACR25, our Dr. Katy Rezvani shared an overview of her team’s wide-ranging CAR NK cell platform target….
0
28
0
Huge congratulations to @Aiims1742 @IamLinghua,and the entire team at @MDAndersonNews and collaborators! Incredible work on advancing our understanding of metastatic #PancreaticCancer—this spatial transcriptomic mapping study in @Nature is a major achievement!.
Congratulations to @IamLinghua @GuangshengPei @jiminmin_v and all our exceptional collaborators at @MDAndersonNews & beyond for today's study in @Nature on spatial mapping of transcriptomic plasticity in metastatic #PancreaticCancer .The full text link is
1
1
16
RT @lab_rezvani: Brilliant work! congratulations, @may_daher and @CollaSimona and co-authors. Fascinating insight into how early NK cell dy….
0
6
0
RT @MDAndersonNews: On this episode of the Cancerwise podcast, Drs. Scott Kopetz and Katy Rezvani break down cell therapy and the different….
0
14
0
“Incredibly proud of my lifelong friend @may_daher and our brilliant collaborator @collasimona for this fantastic paper on my latest favorite topic: MDS/AML. Huge congratulations — and here’s to many more! @MDAndersonNews.
Very excited to share our latest research article published with @SpringerNature in @NatureComms. We show that in early #MDS, NK cells share mutations with the malignant clones, becoming dysfunctional and failing to eliminate aberrant stem cells. This leads to immune evasion and.
2
1
9
RT @Transplant_Doc: Allogeneic NK cells precomplexed with a bispecific (CD30/CD16) NK cell engager (AFM13) in refractory relapsed lymphoma:….
nature.com
Nature Medicine - In this phase 1 trial, patients with heavily pretreated and refractory CD30+ lymphoma were safely treated with donor-cord-blood-derived NK cells that were precomplexed with...
0
10
0
Congratulations to @lab_rezvani,Dr. @YagoNieto & team! Proud to be part of our @NatureMedicine study:AFM13-NK cells in r/r CD30+ lymphomas with incredible results—92.9% ORR, 66.7% CR. First clinical proof of NK redirection!Excited for next-gen NK+engagers! #NKcells #Immunotherapy.
Please check out our paper published in @NatureMedicine on our Phase I trial of AFM13-precomplexed cord blood NK cells in relapsed/refractory CD30+ lymphomas. Led by Dr. Yago Nieto and an outstanding team of coauthors and collaborators, this study marks the first clinical.
0
6
22
0
2
0
RT @RanjanMDPhD: So fun to meet with all these breast cancer experts and talk about stromal barriers to cell therapies along with the brill….
0
3
0
RT @ppisters: It was a superb @GHPartnership Board Meeting today as @MDAndersonNews' Dr. Katy Rezvani shared the groundbreaking work underw….
0
6
0
RT @lab_rezvani: Thank you Dr. Pisters - it was an honor to share the progress being made at the Institute for Cell Therapy Discovery & Inn….
0
9
0
Thank you! @lab_rezvani Honored to share our work on engineered NK cells and the promise of cord blood therapies at #ASTCT. Grateful to be part of such an innovative and collaborative field! #NKCells #CellTherapy @MDAndersonNews.
Congratulations to Dr. Rafet Basar for his outstanding presentation at ASTCT on the promise of cord blood therapies. His talk highlighted our work on engineered NK cells. Grateful for his amazing contributions to the field! #NKCells #ASTCT @MDAndersonNews @rftbsr9
2
1
22